All Stories

  1. Complementary Embryonic and Adult Cell Populations Enhance Myocardial Repair in Rat Myocardial Injury Model
  2. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension
  3. Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary HypertensionNovelty and Significance
  4. rhACE2 in pulmonary hypertension
  5. The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
  6. Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension
  7. Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis
  8. Stem cell therapy restores viscoelastic properties of myocardium in rat model of hypertension
  9. C21, a nonpeptide angiotensin II type 2 receptor agonist attenuates lung fibrosis and associated cardiac dysfunction
  10. Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary HypertensionNovelty and Significance
  11. Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models
  12. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice
  13. In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARγ in L6 myotubes
  14. Upregulation of Glut-4 and PPARγ by an isoflavone from Pterocarpus marsupium on L6 myotubes: a possible mechanism of action